Vertex Pharmaceuticals Incorporated Share Price

Vertex Pharmaceuticals Incorporated Share Price

NASDAQ: VRTX | Large Cap
$540.18
+$10.75 (2.03%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Vertex Pharmaceuticals Incorporated Stock Performance

Open
$536.01
Prev. Close
$529.43
Circuit Range
N/A
Day Range
$535.26 - $546.41
Year Range
$404.67 - $559.22
Volume
1,04,968
Average Traded
$541.24

Vertex Pharmaceuticals Incorporated Share Price Today

As of 30 October 2026, Vertex Pharmaceuticals Incorporated's share price is $540.18. The stock opened at $536.01, compared to its previous close of $529.43. During today's trading session, Vertex Pharmaceuticals Incorporated's share price traded between $535.26 and $546.41, with an average price of $540.84. Over the past 52 weeks, the stock has recorded a high of $559.22 and a low of $404.67. In terms of performance, Vertex Pharmaceuticals Incorporated's share price has risen by 26.37% over the last six months and is up 26.89% on a year-on-year basis.

Vertex Pharmaceuticals Incorporated Share Price Chart

Line chart of the Vertex Pharmaceuticals Incorporated price trend over the selected period. The price rose overall, ranging from 536.70 to 546.38, ending at 540.18.
$535.26$546.41
L
Show Current Price
H

Vertex Pharmaceuticals Incorporated Stock Fundamentals & Key Indicators

Market Cap
$138.12B
PE Ratio (TTM)
30.48
Dividend Yield
0.00%
EPS (TTM)
$17.38
Revenue (TTM)
$12.00B
Return On Equity (TTM)
21.76%
Profit Margin
32.92%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
1.56%

Vertex Pharmaceuticals Incorporated Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$3076.40$3190.00$2986.90$3333.90
Net Profit$1082.90$1191.10$1031.40$1099.80
Net Profit Margin35.20%37.34%34.53%32.99%
Income ChangeN/A9.99%-13.41%6.63%

Vertex Pharmaceuticals Incorporated Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$8.93$9.87$11.02$12.00
Net Profit$3.32$3.62-$0.54$3.95
Net Profit Margin37.18%36.68%-4.90%32.92%
Income ChangeN/A9.04%-114.92%831.48%

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex is focused on diversifying its portfolio through Casgevy (gene-editing therapy for beta thalassemia and sickle-cell disease), Journavx (non-opioid pain drug for moderate-to-severe acute pain), and Palsonify (for acromegaly). Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases, cell therapies to deliver a functional cure for type 1 diabetes, povetacicept (for IgA nephropathy).

Vertex Pharmaceuticals Incorporated Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$523.51
$540.24
+3.26%
Sep 2026
$549.24
$523.18
-4.42%
Aug 2026
$483.35
$547.38
+14.75%
Jul 2026
$501.90
$477.02
-3.92%
Jun 2026
$440.50
$496.46
+10.96%
May 2026
$425.07
$447.44
+4.68%
Apr 2026
$450.98
$427.45
-4.26%
Mar 2026
$495.52
$446.48
-10.14%
Feb 2026
$467.99
$496.83
+5.72%
Jan 2026
$453.32
$469.95
+3.64%
Dec 2025
$432.72
$453.46
+4.64%
Nov 2025
$429.11
$433.35
+1.79%

VRTX Share Price FAQs